跳到正文
原文
Nature 健康护理主题·· 2026-10-14AI 评分33

埃及肥胖女性中脂肪酸与氨基酸摄入对促炎及抗炎平衡的营养调节作用

Nutritional modulation of pro- and anti-inflammatory balance in egyptian women with obesity: the impact of fatty acids and amino acid consumption profiles

AI 导读

一项针对90名埃及女性的观察性横断面研究发现,饮食中脂肪酸和氨基酸的摄入模式与肥胖女性的免疫失调相关。研究比较了60名肥胖女性(平均BMI 38.39 kg/m²)和30名正常体重对照组(平均BMI 22.19 kg/m²),评估了二者间白介素-10(IL-10)、白介素-17(IL-17)及TH17细胞反应的差异。

正文

.

Introduction

Obesity has become a major global health challenge, marked not only by excessive fat accumulation but also by significant disturbances in immune function1. It results from a complex interplay of genetic and environmental factors, including cultural and societal influences on dietary habits, as well as reduced levels of physical activity2.

Increasing evidence indicates that adipose tissue functions as an immunological organ, producing cytokines that contribute to chronic low-grade inflammation and metabolic dysfunction. Specifically, pro-inflammatory pathways mediated by T helper 17 (TH17) cells and cytokines such as interleukin-17 (IL-17) play a central role in obesity-related complications, whereas anti-inflammatory cytokines such as interleukin- 10 (IL-10) act to lessen these effects3.

This interplay between metabolism and immunity has increased attention on the role of diet as a key regulator of immune responses in obesity.

Dietary composition, particularly the intake of fatty acids and amino acids, is increasingly recognized as a determinant of metabolic and inflammatory status. Recent studies demonstrate that dietary lipids directly influence cytokine production and immune signaling pathways, with saturated fatty acids promoting inflammation and unsaturated fatty acids exert regulatory effects on immune responses4.

Dietary protein and specific amino acids, including branched-chain amino acids (BCAAs), also regulate metabolic pathways and immune cell activation. These nutrients influence pathways associated with insulin resistance, adipose tissue inflammation, and cytokine production5.

Despite these advances, critical gaps remain in understanding the relationship between specific dietary components and immune dysregulation in human populations. Most studies have focused on general dietary patterns or macronutrient distribution, with limited attention of the combined effects of amino acids and fatty acids intake on immune markers. Furthermore, many investigations have primarily examined metabolic outcomes such as lipid profiles or insulin resistance, while fewer have explored detailed immune responses, particularly cytokine networks such as the IL-10/ IL-17 axis in the context of diet6.

In addition, data from Middle Eastern and North African populations remain limited, despite rapid nutritional transitions that have altered dietary habits and increased the prevalence of obesity. Cultural dietary patterns, characterized by a shift toward energy-dense foods with changed fatty acids composition, may uniquely influence immune responses. However, population-specific evidence linking dietary intake to immune dysregulation remains limited, particularly among women, who may exhibit distinct immunometabolic profiles. This lack of region- and sex-specific data limits the generalizability of current findings and underscores the need for targeted research in these populations.

Therefore, this study aims to investigate the associations between dietary amino acids and fatty acids intake and immune dysregulation, as reflected by IL-10, IL-17, and TH17 responses, in Egyptian women with obesity compared with non-obese controls.

Subjects and methods

Study design and participants

This observational cross-sectional study began with 120 participants, of whom 90 completed it. The final sample consisted of 90 adult women aged 25–60 years, including 60 with obesity and 30 healthy individuals of normal weight.

Participants were recruited from National Research Centre (NRC) employees/workers and women attending the Visceral Obesity and Growth Disturbance Clinic. Participants from both sources were screened according to the predefined eligibility criteria and anthropometrically assessed, then classified as women with obesity or normal-weight controls. Eligible participants were randomly selected from the available pool until the required sample size was achieved.

The mean body mass index (BMI) of the obese and control groups was 38.39 ± 0.97 kg/m² and 22.19 ± 0.82 kg/m², respectively.

All participants gave written informed consent after receiving a full explanation of the study objectives, in accordance with the principles of the Declaration of Helsinki. This study was conducted as part of a research project funded by the NRC, Egypt (2022–2024), entitled “Immunity and Obesity: Links with Host Gut Microbiota metabolites, genetic, Nutrition; and Intervention by Natural Plant Extract Supplement or Probiotic” (13th Research Plan of the NRC). Ethical approval was obtained from the NRC Ethical Committee (Registration No. 13060191-1) Fig. 1.

Fig. 1

Flow diagram illustrating participant recruitment, eligibility assessment, group classification, and final inclusion in the study.

Sample selection

Participants were eligible if they were aged between 25 and 60 years and had a BMI ≥ 30 kg/m² (obese group) or 18.5–24.9 kg/m² (control group). Additional inclusion criteria included being non-pregnant, non-lactating, not planning pregnancy during the study period, and being non-smokers or light smokers (fewer than five cigarettes per day).

Exclusion criteria included the use of medications for dyslipidemia, type 2 diabetes, or hypertension, as well as the use of immunomodulatory drugs, corticosteroids, or anti-inflammatory agents. Participants were also excluded if they had taken dietary supplements containing fiber, fish oil, probiotics, or prebiotics within six weeks prior to enrollment. Individuals with a history of severe dietary restrictions (e.g., vegan or ketogenic diets), eating disorders, liver or gastrointestinal diseases, chronic inflammatory conditions (other than obesity), psychiatric disorders requiring treatment, or a history of bariatric or gastrointestinal surgery were not included.

Clinical and anthropometric assessment

All participants underwent detailed medical history taking and physical examination, including anthropometric measurements and blood pressure assessment. Blood pressure was measured using a standard cuff sphygmomanometer with participants seated at rest, and the average of three readings was recorded.

Body weight, height and Mid Waist Circumference (MWC) were measured according to the guidelines of the International Biological Program7. Weight was measured to the nearest 0.01 kg using a calibrated seca scale, with participants barefoot and wearing light clothing. Height was measured to the nearest 0.1 cm using a Holtain portable stadiometer. Body mass index (BMI) was calculated as weight (kg) divided by squared height (m²), and participants were classified accordingly. Waist circumference was measured at the narrowest point using a non-stretchable tape without compressing the skin, and the waist-to-height ratio (W/htR) was calculated.

Laboratory investigations

Venous blood samples were collected after a 12-hour overnight fast by trained personnel at the Medical Excellence Research Center (MERC), NRC, Egypt. Samples were allowed to clot, then centrifuged at 5000 rpm for 10 min, and serum was stored at − 80 °C until analysis.

Serum levels of total cholesterol (TC)8, triglycerides (TG)9, and high-density lipoprotein cholesterol (HDL-C)10 were measured using commercially available kits (STANBIO Laboratory Inc., USA). The total cholesterol/HDL-C ratio was calculated. Low-density lipoprotein cholesterol (LDL-C) was calculated according to an equation developed by11, as follows:

$$ {\text{LDL}} - {\text{C }} = {\text{ Total Cholesterol }} - {\text{ HDL}} - {\text{C }}{-}{\text{ }}\left( {{\text{Triglycerides }}/{\text{ 5}}} \right) $$

Cytokine levels were assessed using enzyme-linked immunosorbent assay (ELISA) kits: human T helper 17 (TH17) (SinoGeneClon Biotech, China; Cat. No. SG-10571), Interleukin-10 (IL-10) (ELK Biotechnology; Cat. No. ELK1142), and Interleukin-17 (IL-17) (ELK Biotechnology; Cat. No. ELK2610), according to the manufacturers’ instructions.

Dietary assessment

Dietary intake was assessed using 24-hour recalls over three consecutive days, including one weekend day, with participants self-reporting all foods and beverages consumed. Portion sizes were estimated using household measures, food models, or photographic aids. Nutrient intakes were analyzed using NutriSurvey (2007)12 Dietary data from the three consecutive 24-hour recalls including a week end day were entered into NutriSurvey 2007, and amino acid intake was calculated based on the nutrient composition of the reported foods. The mean intake across the three recall days was used to represent the participant’s average daily amino acid intake, a method validated for assessing macronutrient and fiber intake13,14,15. Dietary intake was estimated from three consecutive 24-hour dietary recalls including a week end, and the reported amino acid values represent the mean daily intake across the three recall days, rather than the cumulative intake over the three-day period. In addition, a semi-quantitative food frequency questionnaire (FFQ) adapted to Egyptian dietary patterns was administered. The daily nutrient intake was expressed as a percentage of the standardized Recommended Dietary Allowances (RDAs). In this context, the recommended energy intake for females aged 30–60 years exhibits minimal variation, reflecting relatively stable physiological requirements. Furthermore, the participants shared similar occupational profiles and levels of physical activity, supporting the use of a uniform reference for energy intake comparisons.

The %RDA values were calculated according to age- and sex-specific dietary reference intakes as established by the National Academies of Sciences, Engineering, and Medicine and World Health Organization guidelines (2006)16, which are widely used for standardizing nutrient intake in epidemiological studies.

Statistical analysis

Prior to analysis, the assumptions of normality and homogeneity of variances were assessed. Homogeneity of variances was evaluated using Levene’s test.

Sample size estimation was performed using the G*Power software to detect correlations between IL-10, IL-17, and the studied variables. Assuming a correlation coefficient of r = 0.30, a statistical power of 80%, and a significance level (α) of 0.05, the minimum required sample size was calculated to be 84 participants. A total of 90 participants were ultimately included, providing sufficient power for correlation analyses, group comparisons, and multivariable regression models. This sample size allows for the detection of moderate effect sizes (Cohen’s d ≈ 0.6) in two-group comparisons and f² ≈ 0.15 in regression analyses with up to 5–7 predictors.

Statistical analyses were performed using IBM SPSS Statistics for Windows, Version 23.0 (IBM Corp., Chicago, IL, USA). Given that the sample size exceeded 50, the normality of data distribution was evaluated using the Kolmogorov–Smirnov test, which indicated no significant deviation from normality (p = 0.200). Continuous variables are expressed as mean ± standard error (SE).

Comparisons between groups were conducted using the independent samples t-test or one-way analysis of variance (ANOVA), as appropriate. The assumption of homogeneity of variances was assessed using Levene’s test, with no significant violations detected (p > 0.05), thereby supporting the application of standard one-way ANOVA, which was primarily employed to explore crude associations between variables in this observational cross section study.

Categorical variables were analyzed using the chi-square test, with Bonferroni correction applied when necessary. Correlations between anthropometric indices, dietary factors, and inflammatory markers were evaluated using Pearson correlation coefficients separately within each study group (normal-weight controls and women with obesity), to examine unadjusted associations between the studied variables. Statistical significance was defined as p < 0.05).

Results

The anthropometric and clinical characteristics of the study participants are presented in Table (1). Compared with controls, women with obesity had significantly higher body weight, BMI, MWC, and W/HtR (all p ≤ 0.001). Diastolic blood pressure was also significantly higher in the obese group (p < 0.05), whereas no significant difference was observed in systolic blood pressure between the two groups.

Table (2) shows the frequency of consumption of different food groups. No marked difference was observed between the two groups in the daily intake of bread and bakery products, with the majority of subjects in both groups consuming these items ≥ 3 times/day. A higher frequency of animal protein intake was observed among the obese group, where 83.33% of them consumed egg and 66.67% of them consumed chicken, meat and fish ≥3times / week compared to 58.93, 62.50% in the control group respectively. In contrast, plant-based protein food intake was relatively higher among controls, with 41.67% consuming legumes ≥ 3 times/week versus 32.14% in the obese group. Similarly, higher consumption of vegetables (58.33%) and fruits (66.67%) was detected in the control group compared to 35.71% and 39.29% in the obese group, respectively. Additionally, frequent consumption of sweets, pastries, and beverages was more dominant among obese participants.

The quantitative assessment of nutrient intake and its adequacy relative to recommended dietary allowances (RDAs) is summarized in Table (3). Energy consumption was significantly higher in obese subjects compared with controls (p ≤ 0.001), reaching approximately 100% of the RDA, while controls achieved lower percentages. Protein intake exceeded the RDA in both groups, without significant difference. While, carbohydrate intake remained below the recommended level in both groups. In contrast, total fat intake was significantly higher in the obese group (p ≤ 0.01), exceeding the RDA, while it remained within recommended levels in controls. Saturated fatty acids (SFAs) intake was also significantly elevated among obese subjects (p ≤ 0.05), while unsaturated fatty acids (UFAs), including monounsaturated (MUFAs) and polyunsaturated fatty acids (PUFAs), were significantly lower in the obese group compared to controls (p ≤ 0.05 for all). Moreover, cholesterol intake was significantly higher in obese participants (p ≤ 0.01), exceeding recommended levels in both groups but to a greater extent among the obese. Dietary fiber intake was significantly lower in obese subjects compared to controls (p ≤ 0.01), with both groups failing to meet the recommended intake.

A detailed analysis of dietary amino acids and fatty acids is presented in Table (4). Total protein intake did not differ significantly between groups. However, obese participants had significantly higher intakes of several amino acids, including leucine, isoleucine, valine, glutamine, and arginine (all p ≤ 0.05), while cysteine intake showed no significant difference.

With respect to fatty acid composition, total fat intake and saturated fatty acids were significantly higher in the obese group (p ≤ 0.05), whereas unsaturated fatty acids, including mono unsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs), were significantly lower (all p ≤ 0.05). Intake of omega-3 and omega-6 fatty acids, including linoleic acid, alpha-linolenic acid, eicosapentaenoic acid (EPA), and docosapentaenoic acid (DPA), was significantly lower in obese participants compared with controls (all p ≤ 0.05). The omega-6/omega-3 ratio also differed significantly between groups.

Table (5) represents the comparison of lipid profile parameters, anti-inflammatory and pro-inflammatory cytokines, and T helper 17 (TH17) cells between obese and control groups. No statistically significant differences were observed between the two groups in TC, TG, or HDL-C levels. However, LDL-C was significantly higher in obese subjects compared to controls (p ≤ 0.05). Regarding cytokines, IL-10 levels were significantly higher in the obese group (p ≤ 0.05), while IL-17 levels did not differ significantly between groups. TH17 cell levels were significantly higher in obese participants compared with controls (p ≤ 0.05).

Correlation analyses are presented in Tables 6 and 7. In women with obesity, IL-17 showed significant positive correlations with BMI, total dietary protein, leucine, valine, cysteine, total dietary fat, and saturated fatty acids, and negative correlations with arginine, unsaturated fatty acids, MUFAs, PUFAs, linoleic acid, α-linolenic acid, EPA, and DPA. In contrast, IL-10 showed significant negative correlations with BMI, WHtR, total dietary protein, isoleucine, valine, cysteine, total dietary fat, and saturated fatty acids, and positive correlations with glutamine, arginine, unsaturated fatty acids, MUFAs, PUFAs, linoleic acid, α-linolenic acid, EPA, and DPA (all p ≤ 0.05). In normal-weight controls, IL-17 showed positive correlation with saturated fatty acids and negative correlations with WHtR, unsaturated fatty acids, MUFAs, PUFAs, linoleic acid, and α-linolenic acid, whereas IL-10 showed negative correlation with WHtR and total dietary fat and positive correlation with unsaturated fatty acids (all p ≤ 0.05). It was observed that the obese group showed more frequent and consistent dietary–cytokine correlations than the control group.

Table 1 Anthropometric and clinical characteristics of obese and normal-weight women.

Full size table

Table 2 Dietary patterns and food frequency intake among obese and normal-weight women.

Full size table

Table 3 Daily energy and nutrient intake and the % of the RDA among obese and normal-weight women.

Full size table

Table 4 Dietary Amino Acid and Fatty Acid Intake and their % of the RDA Among Obese and Normal-Weight Women.

Full size table

Table 5 Lipid Profile and Cytokine Levels in Obese and Normal-Weight Women.

Full size table

Table 6 Pearson’ s Correlations Between Anthropometric Parameters, Dietary Intake, and Cytokine Levels in Obese and Normal-Weight Women.

Full size table

Table 7 Summary of Significant Correlations Between Dietary Components and Cytokine Levels.

Full size table

Discussion

Obesity is a growing global health concern characterized by chronic low-grade.

inflammation that plays a central role in metabolic dysfunction17. The present study aimed to investigate the associations between dietary amino acids and fatty acids intake and cytokine-mediated immune dysregulation (specifically IL-10, IL-17, and TH17 cell levels) in Egyptian women with obesity.

The results showed that the elevated anthropometric indices, including BMI, MWC, and W/htR, reflect central adiposity, which is closely linked to inflammatory activation. Importantly, BMI was positively correlated with IL-17 and negatively correlated with IL-10. However, IL-17 levels did not differ significantly between women with obesity and normal-weight controls, and therefore the observed association with BMI should be interpreted in the context of the within-group correlation analysis. These findings are consistent with recent evidence showing that obesity increases TH17 cell proliferation and stimulates IL-17 production in adipose tissue, thus contributing to systemic inflammation and metabolic dysfunction18.

In addition, the current findings may be partly explained by sex-specific immune regulation, as IL-10 production has been shown to be differentially modulated in women with obesity, reflecting complex immunometabolic adaptations19.

However, inflammatory responses in obesity are not constant across all individuals, and the concept of metabolically healthy obesity suggests that excess adiposity alone may not fully determine immune dysregulation. This highlights the important association of dietary habits and lifestyle factors with inflammatory status20.

Interestingly, current data indicates that IL-10 levels were significantly elevated in obese participants despite increased TH17 activity, suggesting a compensatory anti-inflammatory response. This observation is supported by previous studies indicating that IL-10 may increase as a regulatory mechanism in chronic inflammatory states, particularly among women with obesity19.

In addition, the study demonstrates that amino acid intake is significantly associated with immune markers, supporting the concept that protein quality, rather than quantity alone, plays a key role in immunometabolic regulation. Interleukin-17 was positively correlated with total protein intake and with specific amino acids such as leucine, valine, and cysteine, while IL-10 showed negative correlations with several amino acids. These findings indicate associations between higher intake of certain amino acids, particularly BCAAs, and a more pro-inflammatory profile, rather than demonstrating a direct effect of these amino acids on inflammation. This is consistent with recent evidence linking dietary amino acid profiles to cardiometabolic risk and inflammation in obesity21. BCAAs have been shown to activate mTOR signaling pathways, which regulate immune cell activity and cytokine production, thereby contributing to inflammation22.

On the other hand, the current analysis shows that glutamine was positively correlated with IL-10, that may indicate a potential anti-inflammatory association. This finding is in line with previous studies indicating that glutamine supports immune regulation by modulating immune cell metabolism and enhancing anti-inflammatory cytokine production23. Collectively, these findings highlight that different amino acids may be associated with distinct and sometimes opposing patterns on immune function depending on their metabolic roles and balance within the diet.

Here we found that the obese participants consumed significantly higher amounts of total fat, saturated fatty acids, and cholesterol, alongside lower intakes of unsaturated fatty acids and dietary fiber. These findings are in agreement with dietary patterns known to promote chronic low-grade inflammation. Remarkably, total fat intake was positively associated with IL-17 and negatively associated with IL-10, also suggesting that not only the quantity but also the quality of dietary fat may be associated with differences in immune regulation. Specifically, saturated fatty acids showed a clear pro-inflammatory pattern, being positively correlated with IL-17 and negatively correlated with IL-10. The findings are in accordance with prior mechanistic and clinical studies demonstrating that saturated fatty acids activate inflammatory pathways, including toll-like receptor 4 (TLR4) and NF-κB signaling, leading to increased cytokine production24,25. Furthermore, recent evidence supports that diets high in saturated fats are major contributors to persistent low-grade inflammation in obesity26.

In contrast, the present analysis shows that unsaturated fatty acids, including MUFAs and PUFAs, were inversely associated with IL-17 and positively associated with IL-10. Omega-3 fatty acids such as EPA and DPA demonstrated consistent associations with the inflammatory markers assessed. These findings reinforcing existing evidence indicating that omega-3 fatty acids help in regulating immune responses by reducing pro-inflammatory cytokines and enhancing anti-inflammatory pathways27.

Similarly, adherence to anti-inflammatory dietary patterns such as the Mediterranean diet has been shown to reduce inflammatory markers, further supporting the potentially association of unsaturated fatty acids with inflammatory status28. However, variability in response across studies suggests that factors such as metabolic status, genetic predisposition, and gut microbiota may influence how individuals respond to dietary fat intake29.

Finally, the present work shows that correlations between dietary factors and immune markers were stronger and more numerous in the obese group compared with controls, suggesting that diet and immune interactions are more tightly interconnected in the context of metabolic dysfunction. These findings may indicate that dietary and immune interactions differ according to metabolic status; however, the cross-sectional design does not establish that obesity increases sensitivity to dietary influences or that these dietary factors exacerbate inflammatory responses. Overall, these findings are consistent with recent literature emphasizes that diet represents a key modifiable factor in the regulation of inflammation and immune function in obesity26,28.

Conclusion

Dietary fatty acid and amino acid intake patterns were associated with inflammatory markers among Egyptian women with obesity. The observed associations, particularly those involving omega-3 fatty acids and selected amino acids, suggest potential relationships between dietary composition and inflammatory status. However, given the cross-sectional design and the lack of causal inference, these findings should be interpreted as associative. The observed associations between dietary amino acid/fatty acid intake and inflammatory markers should be interpreted cautiously because differences in adiposity and associated metabolic characteristics between women with obesity and normal-weight participants may contribute to these associations. Therefore, the correlations should not be interpreted as evidence that dietary fatty acids or amino acids are independently related to inflammation unless the potential influence of adiposity and other major confounders has been considered. Further longitudinal and interventional studies are needed to determine whether these dietary factors directly influence inflammatory responses.

Strengths and limitations

The present study has several strengths, notably the integration of detailed dietary assessments with cytokine profiling and anthropometric measurements, allowing for a comprehensive evaluation within the field of nutritional immunology. Moreover, focusing on Egyptian women helps fill an important gap in the literature, as research involving Middle Eastern populations is still limited.

However, some limitations should be considered. The cross-sectional design allows identification of associations but does not establish causal relationships between dietary intake and inflammatory status, and the observed associations cannot distinguish the contribution of specific dietary factors from that of adiposity and related metabolic characteristics. In addition, dietary data were collected using self-reported 24-hour recalls and food frequency questionnaires, which are prone to recall bias and inaccuracies in reporting nutrient intake. The relatively small sample size may also restrict the generalizability of the findings. Furthermore, excluding individuals with certain health conditions or behaviors (such as smokers or those using specific medications) may have reduced the diversity of the study population.

Finally, the correlation analyses were unadjusted for potential confounding factors, including adiposity, total energy intake, overall dietary composition and recruitment site; therefore, the observed associations should not be interpreted as independent relationships. Thus, the observed correlations should be considered exploratory and may not reflect associations that would remain after adjustment for these potential confounding factors.

Despite these limitations, the study offers novel, region-specific insights into the association between dietary amino acid and fatty acid intake and immune dysregulation in obesity, providing a foundation for future longitudinal and interventional research.

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request, after taking the permission of our institute, “National Research Centre”.

References

  1. Abad-Jiménez, Z., Vezza, T. & Obesity A global health challenge demanding urgent action. Biomedicines 13 (2), 502. https://doi.org/10.3390/biomedicines13020502 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hassan, N. E. et al. Lifestyle, socioeconomic disparities and intestinal microbiota in a sample of obese Egyptian women. J. Arab. Soc. Med. Res. 20 (1), 50–60. https://doi.org/10.4103/jasmr.jasmr_35_24 (2025).

    Article  Google Scholar 

  3. bdelnabi, M. N., Hassan, G. S. & Shoukry, N. H. Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease. Front. Immunol. 15, 1437046. https://doi.org/10.3389/fimmu.2024.1437046 (2024).

    Article  CAS  Google Scholar 

  4. Poosri, S., Vimaleswaran, K. S. & Prangthip, P. Dietary lipids shape cytokine and leptin profiles in obesity-metabolic syndrome implications: A cross-sectional study. PLoS One. 19 (12), e0315711. https://doi.org/10.1371/journal.pone.0315711 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Al-Ibraheem, A. M. T. et al. Exercise-induced cytokines, diet, and inflammation and their role in adipose tissue metabolism. Health Sci. Rep. 7 (9), e70034. https://doi.org/10.1002/hsr2.70034 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  6. Hemami, R. M. et al. Dietary fatty acid pattern and its association with metabolic profile among overweight and obese adults. BMC Endocr. Disord. 24, 141. https://doi.org/10.1186/s12902-024-01662-w (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hiernaux, J. & Tanner, J. Growth and physical studies. In: (eds Weiner, J. S. & Lourie, S. A.) Human biology: a guide to field methods. Oxford: Blackwell Scientific; (1969).

    Google Scholar 

  8. Allain, C. C. et al. Enzymatic determination of total serum cholesterol. Clin. Chem. 20 (4), 470–475. https://doi.org/10.1093/clinchem/20.4.470 (1974).

    Article  CAS  PubMed  Google Scholar 

  9. Fossati, P. & Prencipe, L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 28 (10), 2077–2080. https://doi.org/10.1093/clinchem/28.10.2077 (1982).

    Article  CAS  PubMed  Google Scholar 

  10. Warnick, G. R. & Albers, J. J. A comprehensive evaluation of the heparin–manganese precipitation procedure for estimating high density lipoprotein cholesterol. J. Lipid Res. 19 (1), 65–76. https://doi.org/10.1016/S0022-2275(20)42456-3 (1978).

    Article  CAS  PubMed  Google Scholar 

  11. Haines, C. J. et al. Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23. Cell. Rep. 3 (5), 1378–1388. https://doi.org/10.1016/j.celrep.2013.04.005 (2013).

    Article  CAS  PubMed  Google Scholar 

  12. Nutri survey. Nutrition Survey and Calculation Guidelines, Software and additional Information for Windows – Cop (2007) (Last page modification: April 2nd, 2010. Dr. Juergan Ethardt – SEAMEO-TROPMEP. RCCN-University of Indonesia. (2007). www.nutrisurvey.de/ena/ena.html

  13. Mahfouz, E. M., Mohammed, E. S., Alkilaet, S. F. & Abdel Rahman, T. A. The relationship between dietary intake and stunting among pre-school children in Upper Egypt (Public Health Nutrition, 2021). https://doi.org/10.1017/S1368980021003656

  14. El Shebini, S. M. et al. Serum Level of Uromdulin as an early predictor of kidney disorders. OA Maced J. Med. Sci. 02 (B), 167–175. https://doi.org/10.3889/oamjms.2021.5663 (2021).

    Article  Google Scholar 

  15. Zaki, M., Hussein, L., Gouda, M., Bassuoni, R. & Hassanein, A. Nutritional epidemiological study to estimate usual intake and to define optimum nutrient-profiling choice in the diet of Egyptian youths. Food Nutr. Sci. 6 (15), 1387–1399. https://doi.org/10.4236/fns.2015.615147 (2015).

    Article  CAS  Google Scholar 

  16. National Academies of. Sciences, Engineering, and Medicine. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements (National Academies, 2006).

  17. Gkrinia, E. M. M. & Belančić, A. The mechanisms of chronic inflammation in obesity and potential therapeutic strategies: a narrative review. Curr. Issues Mol. Biol. 47 (5), 357. https://doi.org/10.3390/cimb47050357 (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Alhamawi, R. M. et al. Investigating the potential role of T helper 17 cells among women experiencing overweight and obesity and their possible therapeutic targeting of the RORγt molecule. Sci. Rep. 14, 29279. https://doi.org/10.1038/s41598-024-81070-1 (2024).

    Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

  19. Subramanian, N. S. N. et al. Sex-specific regulation of IL-10 production in human adipose tissue in obesity. Front. Endocrinol. (Lausanne). 13, 996954. https://doi.org/10.3389/fendo.2022.996954 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wani, K. et al. Exploring inflammation and adipose tissue dysfunction in metabolically healthy versus unhealthy obesity among Arab adults. Diabetol. Metab. Syndr. 17, 244. https://doi.org/10.1186/s13098-025-01836-z (2025).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Alijani, F. et al. The relationship between amino acid intake patterns and both general and central obesity. BMC Nutr. 11, 87. https://doi.org/10.1186/s40795-025-01073-7 (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  22. Mei, J., Yang, F. Y. & Gong, Q. Branched-chain amino acids and insulin resistance in type 2 diabetes: from metabolic dysregulation to therapeutic targets. Front. Endocrinol. (Lausanne). 16, 1643231. https://doi.org/10.3389/fendo.2025.1643231 (2026).

    Article  PubMed  PubMed Central  Google Scholar 

  23. Fan, Y. & Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 19 (1), 55–71. https://doi.org/10.1038/s41579-020-0433-9 (2021).

    Article  CAS  PubMed  Google Scholar 

  24. Zhou, H., Urso, C. J. & Jadeja, V. Saturated fatty acids in obesity-associated inflammation. J. Inflamm. Res. 13, 1–14. https://doi.org/10.2147/JIR.S229691 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Huang, Y. et al. Lauric-α-linolenic lipids modulate gut microbiota, preventing obesity, insulin resistance and inflammation in high-fat diet mice. npj Sci. Food. 8, 115. https://doi.org/10.1038/s41538-024-00349-9 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Fic, W. & Polak-Szczybyło, E. Dietary factors influencing the intensity of low-grade inflammation in obesity. Obesities 5 (1), 12. https://doi.org/10.3390/obesities5010012 (2023).

    Article  Google Scholar 

  27. Torres-Vanegas, J. et al. Effect of a diet supplemented with marine omega-3 fatty acids on inflammatory markers in subjects with obesity: a randomized active placebo-controlled trial. Healthc. (Basel). 13 (2), 103. https://doi.org/10.3390/healthcare13020103 (2025).

    Article  Google Scholar 

  28. Keshani, M. et al. Mediterranean diet reduces inflammation in adults: a systematic review and meta-analysis of randomized controlled trials. Nutr. Rev. nuaf213. https://doi.org/10.1093/nutrit/nuaf213 (2025).

  29. Tilg, H., Zmora, N., Adolph, T. E. & Elinav, E. The intestinal microbiota fuelling metabolic inflammation. Nat. Rev. Immunol. 20 (1), 40–54. https://doi.org/10.1038/s41577-019-0198-4 (2020).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge our institute, “National Research Centre’; Egypt”; without their support, this study could not be done. Authors are also grateful to everyone who participated in this study: the employers of our institute, the technicians who helped with laboratory analysis, and the doctors who participated in data collection. Without their help, this study couldn’t have been completed.

Author information

Authors and Affiliations

  1. Biological Anthropology Dept, Medical Research and Clinical Studies Institute, Giza, Egypt

    Nayera E. Hassan, Sahar A. El-Masry, Aya Khalil, Doaa Y. Hammad, Ayat N. Kamal, Ahmed S. Ismail, Khadija M. Alian, Mahmoud A. S. Afify, Safinaz Megahed, Galal I. Elashry, Ebrahim Ebrahim & Heba T. Aboud

  2. Nutrition and Food Science Dept, Nutrition and Food Science Institute, Giza , Egypt

    Salwa M. El Shebini, Nihad H. Ahmed & Maha I. A. Moaty

  3. Clinical and Chemical Pathology Dept, Medical Research and Clinical Studies Institute, Giza, Egypt

    Enas Abdel Rasheed

  4. Hormones Department, Medical Research and Clinical Studies Institute, Giza, Egypt

    Mohamed S. Kishta

  5. Researches and Applications of Complementary Medicine, Medical Research and Clinical Studies Institute, National Research Centre, El-Bohooth St. (El-Tahrir St. previously), Dokki, Giza, Egypt

    Mohamed Selim

Authors

  1. Nayera E. Hassan
  2. Salwa M. El Shebini
  3. Nihad H. Ahmed
  4. Sahar A. El-Masry
  5. Maha I. A. Moaty
  6. Aya Khalil
  7. Doaa Y. Hammad
  8. Ayat N. Kamal
  9. Ahmed S. Ismail
  10. Khadija M. Alian
  11. Mahmoud A. S. Afify
  12. Safinaz Megahed
  13. Galal I. Elashry
  14. Ebrahim Ebrahim
  15. Enas Abdel Rasheed
  16. Mohamed S. Kishta
  17. Mohamed Selim
  18. Heba T. Aboud

Contributions

N. E. Hassan is the Principal investigator (P.I.), designed the project and the study as well revised every step of the project, and gave conceptual advice; S. M. El Shebini, shared in the design of the study and writing the draft of the manuscript; S. A. El-Masry is the Co-PI of the project from which this data was derived, and shared in tabulation of the data and publication process; N. H. Ahmed performed the statistical analysis; A. N. Kamal and H. T. Aboud shared in writing the primary draft of the manuscript and publication process; E. Abdel Rasheed and Mohamed S. Kishta responsible about the laboratory investigations, Kh. M. Alian, M.A. S. Afify, M.I. A. Moaty and A. N. Kamal responsible about the nutritional assessment;, A. Khalil, D. Y. Hammad, S.Megahed, A.S. Ismail , G.Ismail Elashry, E. Ebrahim, and M. Selim, had taken anthropology measurements. All authors contributed to the collection of references and drafting of the article. They have accepted responsibility for the entire content of this submitted manuscript and approved the submission. They have agreed both to be personally accountable for the author’s contributions and to ensure that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and the resolution documented in the literature.

Corresponding author

Correspondence to Heba T. Aboud.

Ethics declarations

Competing interests

The authors declare no competing interests.

Financial support

This study was in the context of a large project titled: ‘Immunity and Obesity: Links with Host Gut Microbiota metabolites, genetic, Nutrition; and Intervention by natural plant extract supplement or Probiotic’, supported by the National Research Centre, Egypt, from 2022 to 2023, during the research plan number 13.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hassan, N.E., El Shebini, S.M., Ahmed, N.H. et al. Nutritional modulation of pro- and anti-inflammatory balance in egyptian women with obesity: the impact of fatty acids and amino acid consumption profiles. Sci Rep 16, 32247 (2026). https://doi.org/10.1038/s41598-026-72443-9

Download citation

  • Received: 25 May 2026

  • Accepted: 16 September 2026

  • Published: 14 October 2026

  • Version of record: 14 October 2026

  • DOI: https://doi.org/10.1038/s41598-026-72443-9

Keywords

来源:Nature 健康护理主题 · nature.com